A detailed history of American Century Companies Inc transactions in Pulmonx Corp stock. As of the latest transaction made, American Century Companies Inc holds 28,954 shares of LUNG stock, worth $240,028. This represents 0.0% of its overall portfolio holdings.

Number of Shares
28,954
Previous 27,682 4.6%
Holding current value
$240,028
Previous $256,000 28.52%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

BUY
$5.77 - $9.82 $7,339 - $12,491
1,272 Added 4.6%
28,954 $183,000
Q1 2024

May 14, 2024

BUY
$8.71 - $14.65 $42,374 - $71,272
4,865 Added 21.32%
27,682 $256,000
Q4 2023

Feb 13, 2024

BUY
$7.89 - $13.14 $180,026 - $299,815
22,817 New
22,817 $290,000
Q3 2023

Nov 13, 2023

BUY
$9.88 - $14.0 $67,608 - $95,802
6,843 Added 43.9%
22,431 $231,000
Q2 2023

Aug 14, 2023

BUY
$10.78 - $13.65 $168,038 - $212,776
15,588 New
15,588 $204,000

Others Institutions Holding LUNG

About Pulmonx Corp


  • Ticker LUNG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,268,400
  • Market Cap $309M
  • Description
  • Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...
More about LUNG
Track This Portfolio

Track American Century Companies Inc Portfolio

Follow American Century Companies Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.